ACE2 and COVID-19: Oppositely to what has been hypothesized for the first stage, increased attached ACE2 during the second stage is likely correlated with favorable outcomes, since ACE2 may limit the cytokine storm that underlies the Acute Respiratory Distress Syndrome (ARDS) in COVID-19.